June 20, 2025

Get In Touch



Sodium Bicarbonate Not To Be Recommended For Cancer Treatment-Associated Oral Mucositis: Study

Sodium Bicarbonate and Oral Mucositis

Sodium Bicarbonate and Oral Mucositis

Sodium bicarbonate should not be prescribed or recommended for cancer treatment-associated oral mucositis suggests a recent study published in the BMC Oral Health.

Oral mucositis (OM) is a major side effect of cancer therapy, which is associated with significant symptoms, treatment delays, and increased costs for the health system. It is an important component of the quality of life of cancer patients and, until now, there has been no gold standard regarding prevention or treatment of this pathology. Notwithstanding the paucity of treatment guidelines (due to limited evidence from high-quality, rigorous studies), sodium bicarbonate (SB) rinses are one of the most used agents for Oral mucositis management.

A systematic review (2000–2022) was performed in order to compare and examine different agents versus sodium bicarbonate (SB) in preventing or treating Oral mucositis. Eleven randomized controlled trials (RCT) were evaluated: four were conducted for the prevention and seven for the management of Oral mucositis. The risk of bias of RCTs was assessed using the revised Cochrane risk of bias tool for randomized trials. According to the RoB2 evaluation for randomized trials, four RCTs were judged to be at a high risk of bias, two were rated as ‘problematic’, while five were deemed to be a low risk of bias.

The results revealed that there was no evidence for supporting Sodium bicarbonate in Oral mucositis treatment regarding management and prevention. Results showed in this review takes on a strategic importance in the use of Sodium bicarbonate for Oral mucositis management or prevention; indiscriminate use of Sodium bicarbonate could be counterproductive because it causes a sudden pH increase and it delays proper Oral mucositis pharmacological treatment.

Reference

Di Fede, O., Canepa, F., Maniscalco, L. et al. Prevention and the treatment of oral mucositis: the efficacy of sodium bicarbonate vs other agents: a systematic review. BMC Oral Health 23, 4 (2023). https://doi.org/10.1186/s12903-022-02586-4

Keywords

  • Sodium bicarbonate
  • Prescribed
  • Recommended
  • Cancer treatment–associated
  • Oral mucositis
  • BMC Oral Health
  • Di Fede, O.
  • Canepa, F.
  • Maniscalco

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!